 | Up a level |
Number of items: 1.
Gelrud, A. A., Digenio, A., Alexander, V., Williams, K. R., Hsieh, A., Gouni-Berthold, I., Bruckert, E., Stroes, E., Geary, R., Hughes, S., Tsmikas, S., Witztum, J. L. and Gaudet, D. (2017). Treatment With Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients With Familial Chylomicronemia Syndrome (FCS) and Severe Hypertriglyceridemia (sHTG) vs Placebo: Results of the Approach and Compass Studies. Pancreas, 46 (10). S. 1402 - 1403. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1536-4828